Prevalencia de infeccion humana por Trypanosoma cruzi en bancos de sangre en Venezuela

Primary investigations carried out in blood banks in Venezuela during the 1950s, indicated that overall seroprevalence for Trypanosoma cruzi infection was 12% amongst blood donors. In Venezuela, blood donation is free. All public and private blood banks are controlled by the Ministry of Health. As f...

Descripción completa

Detalles Bibliográficos
Autor: Aché, Alberto
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:1993
País:Brasil
Institución:Instituto de Medicina Tropical (IMT)
Repositorio:Revista do Instituto de Medicina Tropical de São Paulo
Idioma:español
OAI Identifier:oai:revistas.usp.br:article/29083
Acceso en línea:https://www.revistas.usp.br/rimtsp/article/view/29083
Access Level:acceso abierto
Palabra clave:Enfermedad de Chagas
Seroprevalencia
transfusiones de sangre
Control
Inmunodiagnosis
Descripción
Sumario:Primary investigations carried out in blood banks in Venezuela during the 1950s, indicated that overall seroprevalence for Trypanosoma cruzi infection was 12% amongst blood donors. In Venezuela, blood donation is free. All public and private blood banks are controlled by the Ministry of Health. As from 1988 the ELISA technique was uniformly used in blood banks for the detection of T. cruzi infections. Annual median seroprevalence, between 1988 to 1992, was 1.20%(1.09 - 1.94%), with geographical variations between localities in several Stales. States with higher prevalence rates are located in the western and central part of Venezuela: Portuguesa, Lara, Trujillo, Cojedes and Carabobo. Due to difficulties in obtaining incidence rates for Chagas disease, it seems proper to use prevalence rates due to its greater stability; and in the specific case of Venezuela, due to a lesser severity and a higher survival of this disease at present. Considering that there is little to be offered to the seropositive individual, repeatibility is avowed for serological diagnosis. Specificity should be strived for in the light of lower prevalence rates at present.